Adaptimmune Therapeutics plc - (NASDAQ:ADAP) Jumps in Trading Today - Up by 8.4490%

Rathbone Brothers plc owned about 0.21% of Adaptimmune Therapeutics PLC worth $900,000 at the end of the most recent quarter. Raymond James Financial Services Advisors Inc. acquired a new stake in Adaptimmune Therapeutics PLC during the 1st quarter worth approximately $120,000. Point72 Asset Management, L.p. augmented its holdings by buying 22,200 shares an increase of 4.2% in the quarter. With an institutional ownership near 58.8%, it carries an earnings per share ratio of -1.

Adaptimmune Therapeutics plc (ADAP) held 79.07 million outstanding shares now. Trading volume was down 19.92% under the stocks average daily volume. Finally, Wellington Management Group LLP lifted its stake in shares of Adaptimmune Therapeutics PLC by 17.4% in the 1st quarter.

As of the end of the quarter Ubs Group Ag had acquired a total of 1,228 shares growing its holdings by 159.1%. Short interest grew from 457,743 to 492,099 over that period.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of USA and global trademark and copyright laws.

10/15/2015 - Adaptimmune Therapeutics plc had its "outperform" rating reiterated by analysts at Cowen.

An earnings forecast is an analyst's outlook for a company's future quarterly or annual earnings. BidaskClub upgraded Adaptimmune Therapeutics PLC from a "sell" rating to a "hold" rating in a report on Sunday, July 16th.

More important recent Adaptimmune Therapeutics PLC - ADR (NASDAQ:ADAP) news were published by: " which released: "Adaptimmune Therapeutics PLC ADR" on November 29, 2014, also published article titled: "8.93", published: "Adaptimmune Therapeutics PLC â€" ADR (NASDAQ:ADAP) Jumps a Big 30% Since Our Buy ..." on September 08, 2017. Its up 43.68% from 300,400 shares, reported previously.

Adaptimmune Therapeutics plc (ADAP)'s RSI (Relative Strength Index) is 84.52.

Analysts on average have given a price target of $12.57 to Adaptimmune Therapeutics plc (ADAP) stock. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. They now have a $15.00 price objective on the biotechnology company's stock.

The share price of Adaptimmune Therapeutics plc (NASDAQ:ADAP) was down -0.90% during the last trading session, with a day high of 9.29. Over the last three months, the shares of the company have changed 80.61% and performed 80.98% over the last six months.

Shares last traded at $8.19 which is significantly higher than the 50 day moving average of $5.62 and much higher than the 200 day moving average of $5.16. The company's market cap is $706.1 Million, and the average volume is 277.31 Million. For the past 5 years, the company's revenue has grown 0%, while the company's earnings per share has grown 0%. Inc. raised its stake in Adaptimmune Therapeutics PLC by 639.5% in the third quarter.

The value of the company's investment in Adaptimmune Therapeutics plc - increased from $4,000 to $9,000 increasing 125.0% since the last quarter. The Firm is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR, and produce TCR therapeutic candidates for administration to patients.

Like this



18 September 2017
Royal Gold Inc (NASDAQ:RGLD) Move as Institutional Investors' Sentiment Up
Tiaa Cref Investment Management Limited Liability Co reported 310,190 shares. 669,296 are owned by Kopernik Global Investors Lc. The Company's assets are located in Canada, Chile, Dominican Republic, Mexico, the United States, Africa, Australia and Other.

18 September 2017
Lumentum Holdings Inc. (LITE) hit its 1-Year High price on 07/26/17
On average, equities research analysts expect that Lumentum Holdings Inc . will post $3.02 EPS for the current fiscal year. Analysts are also projecting an Average Revenue Estimate for Lumentum Holdings Inc .as $256230 in the Current Quarter.

18 September 2017
John Oliver wins Emmys and Twitter with #DCPublicSchools
The Globe's top picks for what to see and do each weekend, in Boston and beyond. When John Oliver utters a hashtag, it's bound to trend.

18 September 2017
Gallo blast helps Rangers to win over Angels
Parker was the last of seven relievers to work in this bullpen game, the Angels' answer to Andrew Heaney's shoulder impingement. Stats: Trout is hitting.315 (113 for 359) with 29 home runs, 65 RBIs and 85 runs scored in 102 games.

18 September 2017
Emmy-nominated Shailene Woodley doesn't own a TV
News' inquiry about her television viewing habits. "If I were to have one, it would be a flip phone". She went on to explain that she chooses being a bookworm over binge-watching.

18 September 2017
The Last of Us Remastered New Patch Enhances Game's PS4 Pro Support
The Last of Us 2 is releasing sometime next year and will pick up the story from where we left off in the first game back in 2013. Additionally, today's patches resolve bugs and exploits identified in Factions Multiplayer.

18 September 2017
Trump 'amnesty' for immigrants infuriates base
Luis Withrow, a Twitter user known for his support of Trump, explained why he was burning his Make America Great Again hat. Democrats on Wednesday night said the deal they made with Trump didn't include funding for Trump's border wall.

18 September 2017
Chelsea tackle Arsenal at Stamford Bridge
Don Hutchison and Alison Bender delve into the differing coaching styles ahead of Chelsea's clash with Arsenal . Arsenal start with Danny Welbeck in attack, supported by Alexandre Lacazette and Alex Iwobi.

18 September 2017
Samsung Galaxy Note 8 breaks 800000 predicted pre-orders in South Korea
The Galaxy Note 8's display is HDR10 compliant, and the phone's capacitive home button actually has force touch capabilities. If you want to future-proof yourself as best as possible, the iPhone 8 , iPhone 8 Plus , and iPhone X are all here for you.

18 September 2017
Emmys: John Lithgow Wins Best Supporting Actor in a Drama Series
Without uttering his name, John Lithgow threw shade at President Trump by praising Winston Churchill at the 69th Emmy Awards. A Netflix original drama, The Crown chronicled the life of Queen Elizabeth II (Claire Foy) from the 1940s to modern times.